IL17A and reactive arthritis: Previous research has linked the IL-23/IL-17 major cytokine pathway to the development of GM (11) as well as spondyloarthritis (SpA), ankylosing spondylitis (AS), reactive arthritis (ReA) (12), and reactive arthritis induced by bacterial infections.